We focus our research on understanding the biology of infection-related cancers with the goal of improving prevention and treatment in low-resource settings. Our researchers are currently engaged in 30 studies and six pending studies that investigate five types of cancer (Kaposi sarcoma, non-Hodgkin lymphomas, including Burkitt lymphoma, cervical cancer, breast cancer and Hodgkin lymphomas) and four viruses (HIV, human herpes and simplex viruses and Epstein-Barr virus).
To date, more than 7,000 Ugandans have participated in our studies. One of these studies resulted in a new blood test to diagnose Epstein-Barr infection and determine whether patients are at higher risk of lymphoma as a result of that infection.
Our specimen repository in Uganda contains more than 100,000 biologic specimens for research. We also work to build multidisciplinary research teams of African physicians, clinical researchers, basic research scientists, epidemiologists, pathologists and support staff.